# Firazyr

NDC: 54092-702
Generic name: icatibant acetate
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20110825

FDA application: NDA022150

## Active ingredients

- ICATIBANT ACETATE: 30 mg/3mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"54092-702"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=54092-702
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed6657ca-ab68-477a-9968-e12dc928b540